Ingenuity Systems releases new IPA software for life science researchers

NewsGuard 100/100 Score

Ingenuity® Systems, the leading provider of information solutions for life science researchers, today announced the addition of dynamic reports, new weekly content updates, and metabolomics workflow support in the latest release of IPA® software.  

Life science researchers need to keep up with increasingly complex developments in the diagnosis, treatment, and etiology of diseases.  Through the new IPA reports, researchers now have a centralized location to summarize and communicate key insights regarding the broader biological and therapeutic relevance of a particular pathway, analysis, or list of molecules (genes, proteins, or chemicals) associated with a disease. IPA reports can be easily shared and have active links so all team members can access valuable, targeted information.  In addition, Ingenuity content updates occur weekly and are manually reviewed, ensuring the knowledge in each report is up-to-date and accurate.  

"The combination of weekly content updates with the new dynamic reports in IPA 8.5 helped numerous translational medicine and systems biology projects at the Erasmus MC to create clear and targeted summaries for several relevant genes associated with the disease we are studying," stated Dr. Andreas Kremer, Research Scientist, Erasmus Medical Center.  "Because of the accuracy of Ingenuity's current and detailed biomedical knowledge, we were able to confidently leverage recent discoveries along with our proprietary data and come to a novel, up-to-date understanding of the relevance of these genes in the context of the disease."

Other high impact features in IPA 8.5 include streamlined metabolomics workflows, collaborative workspaces, and new pathway and disease content.

Source:

Ingenuity Systems

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
News-Medical.net Celebrates 20 Years of Medical Science Reporting